Aurobindo Pharma Ltd received a tentative approval from the U.S. Food and Drug Administration for its generic losartan potassium tablets in multiple strengths.

The drug is the generic equivalent of Merck & Co Inc's (MRK.N: Quote, Profile, Research) anti-hypertensive Cozaar tablets, which had sales of $1.24 billion in 2007, Aurobindo said in a statement. (Reporting by Bharghavi Nagaraju; Editing by Ramya Venugopal)